<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03767985</url>
  </required_header>
  <id_info>
    <org_study_id>MEC-2016-439</org_study_id>
    <nct_id>NCT03767985</nct_id>
  </id_info>
  <brief_title>Patching or Gaming as Amblyopia Treatment?</brief_title>
  <official_title>A Randomised Clinical Trial Objectively Comparing the Effect of Patching Therapy With Video Gaming for Amblyopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lijf &amp; Leven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ODAS Stichting</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uitzicht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Applied Sciences Utrecht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amblyopia affects 3% of the children and is caused by strabismus, anisometropia or both.&#xD;
      Standard treatment is glasses and patching therapy. From North-America, behavioural training,&#xD;
      i.e. dichoptic training, perceptual learning and video gaming, has become increasingly&#xD;
      popular to improve visual acuity not only in children but also in adults. In this study we&#xD;
      aim to compare the standard occlusion therapy with dichoptic video gaming.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Amblyopia affects 3% of the children and is caused by strabismus, anisometropia or both. The&#xD;
      standard treatment is glasses and patching therapy. From North-America, behavioural training,&#xD;
      i.e. dichoptic training, perceptual learning and video gaming, has become increasingly&#xD;
      popular. The rationale behind these games is by using dichoptic stimulation, with the&#xD;
      contrast of the stimuli presented to the good eye reduced to match the appearance of the same&#xD;
      stimuli when shown to the amblyopic eye, suppression can be alleviated. The many studies now&#xD;
      conducted, demonstrate improvement in visual acuity with the games, the effect however is&#xD;
      limited, but the rate of improvement is higher. In these studies, prescribed patching-time&#xD;
      was compared to realised game-time. We have demonstrated in multiple studies that&#xD;
      electronically measured compliance is low: on average only 50%.&#xD;
&#xD;
      In this study we aim to compare the effect of patching therapy, using the ODM to objectively&#xD;
      measure compliance, with the effect of a novel dichoptic action video game in children as&#xD;
      well as in adults. In addition, the adult participants will undergo fMRI scans to document&#xD;
      any changes in the visual cortex before and after either therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 18, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">June 24, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants are randomized to either the standard patching therapy or the dichoptic video game therapy.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>The research orthoptist that does the orthoptic examinations is masked to the randomization.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity improvement</measure>
    <time_frame>24 weeks</time_frame>
    <description>Visual Acuity improvement (logMAR units/time period) in children with amblyopia treated with patching therapy vs dichoptic video gaming</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Amblyopia</condition>
  <arm_group>
    <arm_group_label>Occlusion therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants are prescribed 2 hours of occlusion therapy per day, 7 days a week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dichoptic video game therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive dichoptic video game therapy: 1 hour per week at the out-patient clinic under direct supervision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dichoptic video game therapy</intervention_name>
    <description>Dichoptic video gaming for 1 hour per week, viewed through the Oculus Rift.</description>
    <arm_group_label>Dichoptic video game therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Occlusion therapy</intervention_name>
    <description>Occlusion therapy for 2 hours per day, 7 days a week</description>
    <arm_group_label>Occlusion therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Amblyopia; an interocular difference in visual acuity of at least 2 logMAR lines.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A non-comitant or large angle constant strabismus &gt;30Prism Dioptres, a neurological&#xD;
             disorder, nystagmus, other eye disorders and diminished acuity due to medication,&#xD;
             brain damage or trauma.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johannes R Vingerling, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Erasmus Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sjoukje E Loudon, MD, PhD</last_name>
    <phone>+31(0)624927128</phone>
    <email>s.loudon@erasmusmc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aveen Kadhum, Bsc</last_name>
    <phone>+31 (0)10 7032103</phone>
    <email>a.kadhum@erasmusmc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <state>South-Holland</state>
        <zip>3015 GD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aveen Kadhum, Bsc</last_name>
      <phone>+31 (0)10 7032103</phone>
      <email>a.kadhum@erasmusmc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Emily T.C. Tan, Bsc</last_name>
      <phone>+31(0)650032078</phone>
      <email>e.tan@erasmusmc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Sjoukje E Loudon, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 6, 2018</study_first_submitted>
  <study_first_submitted_qc>December 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2018</study_first_posted>
  <last_update_submitted>August 20, 2021</last_update_submitted>
  <last_update_submitted_qc>August 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasmus Medical Center</investigator_affiliation>
    <investigator_full_name>Sjoukje Elizabeth Loudon</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

